{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T02:25:57Z","timestamp":1658715957831},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/ijir.2016.11","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T08:02:15Z","timestamp":1459411335000},"page":"110-113","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute effect of rosiglitazone on relaxation responses in hypercholesterolemic corpus cavernosum"],"prefix":"10.1038","volume":"28","author":[{"given":"H","family":"Akdag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Murat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Evcim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Esen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Gidener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"BFijir201611_CR1","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/j.1939-4640.2003.tb02743.x","volume":"24","author":"TJ Bivalacqua","year":"2003","unstructured":"Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJG . Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24: S17\u2013S37.","journal-title":"J Androl"},{"key":"BFijir201611_CR2","doi-asserted-by":"publisher","first-page":"839149","DOI":"10.5402\/2011\/839149","volume":"2011","author":"A Castela","year":"2011","unstructured":"Castela A, Vendeira P, Costa C . Testosterone, endothelial health, and erectile function. ISRN Endocrinol 2011; 2011: 839149.","journal-title":"ISRN Endocrinol"},{"key":"BFijir201611_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1745-7262.2008.00372.x","volume":"10","author":"D Xie","year":"2008","unstructured":"Xie D, Annex BH, Donatucci CF . Growth factors for therapeutic angiogenesis in hypercholesterolemic erectile dysfunction. Asian J Androl 2008; 10: 23\u201327.","journal-title":"Asian J Androl"},{"key":"BFijir201611_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/jsm.12482","volume":"11","author":"RA Fraga-Silva","year":"2014","unstructured":"Fraga-Silva RA, Costa-Fraga FP, Faye Y, Sturny M, Santos RA, da Silva RF et al. An increased arginase activity is associated with corpus cavernosum impairment induced by hypercholesterolemia. J Sex Med 2014; 11: 1173\u20131181.","journal-title":"J Sex Med"},{"key":"BFijir201611_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/cvr\/cvn308","volume":"81","author":"H-R Liu","year":"2009","unstructured":"Liu H-R, Tao L, Gao E, Qu Y, Lau WB, Lopez BL et al. Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation\u2014a novel mechanism for the cardioprotective effects of PPAR agonists. Cardiovasc Res 2009; 81: 344\u2013352.","journal-title":"Cardiovasc Res"},{"key":"BFijir201611_CR6","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/01.CIR.0000097003.49585.5E","volume":"108","author":"L Tao","year":"2003","unstructured":"Tao L, Liu H-R, Gao E, Teng Z-P, Lopez BL, Christopher TA et al. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator\u2013activated receptor-\u03b3 agonist in hypercholesterolemia. Circulation 2003; 108: 2805\u20132811.","journal-title":"Circulation"},{"key":"BFijir201611_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","volume":"26","author":"JP Berger","year":"2005","unstructured":"Berger JP, Akiyama TE, Meinke PT . PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 2005; 26: 244\u2013251.","journal-title":"Trends Pharmacol Sci"},{"key":"BFijir201611_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11154-013-9237-9","volume":"14","author":"KJ Mather","year":"2013","unstructured":"Mather KJ . The vascular endothelium in diabetes\u2014a therapeutic target? Rev Endocr Metab Disord 2013; 14: 87\u201399.","journal-title":"Rev Endocr Metab Disord"},{"key":"BFijir201611_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18433\/J3TG6H","volume":"11","author":"B Gholamine","year":"2008","unstructured":"Gholamine B, Shafiei M, Motevallian M, Mahmoudian M . Effects of pioglitazone on erectile dysfunction in sildenafil poor-responders: a randomized, controlled study. J Pharm Pharmaceut Sci 2008; 11: 22\u201331.","journal-title":"J Pharm Pharmaceut Sci"},{"key":"BFijir201611_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejphar.2011.03.030","volume":"660","author":"HK Elcioglu","year":"2011","unstructured":"Elcioglu HK, Kabasakal L, Ozkan N, Celikel C, Ayanoglu-Dulger G . A study comparing the effects of rosiglitazone and\/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues. Eur J Pharmacol 2011; 660: 476\u2013484.","journal-title":"Eur J Pharmacol"},{"key":"BFijir201611_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/ijir.2010.8","volume":"22","author":"BC Soner","year":"2010","unstructured":"Soner BC, Murat N, Demir O, Guven H, Esen A, Gidener S . Evaluation of vascular smooth muscle and corpus cavernosum on hypercholesterolemia. Is resveratrol promising on erectile dysfunction[quest]. Int J Impot Res 2010; 22: 227\u2013233.","journal-title":"Int J Impot Res"},{"key":"BFijir201611_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000330092","volume":"88","author":"Y Mendizabal","year":"2011","unstructured":"Mendizabal Y, Llorens S, Nava E . Effects of pioglitazone and rosiglitazone on vascular function of mesenteric resistance arteries in rat genetic hypertension. Pharmacology 2011; 88: 72\u201381.","journal-title":"Pharmacology"},{"key":"BFijir201611_CR13","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/j.1939-4640.2003.tb02743.x","volume":"24","author":"TJ Bivalacqua","year":"2003","unstructured":"Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ . Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24: S17\u2013S37.","journal-title":"J Androl"},{"key":"BFijir201611_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejphar.2005.05.012","volume":"517","author":"N Shukla","year":"2005","unstructured":"Shukla N, Jones R, Persad R, Angelini GD, Jeremy JY . Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol 2005; 517: 224\u2013231.","journal-title":"Eur J Pharmacol"},{"key":"BFijir201611_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0021-9150(01)00740-7","volume":"162","author":"D Behr-Roussel","year":"2002","unstructured":"Behr-Roussel D, Bernabe J, Compagnie S, Rupin A, Verbeuren TJ, Alexandre L et al. Distinct mechanisms implicated in atherosclerosis-induced erectile dysfunction in rabbits. Atherosclerosis 2002; 162: 355\u2013362.","journal-title":"Atherosclerosis"},{"key":"BFijir201611_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1517\/14728222.10.3.445","volume":"10","author":"AL Burnett","year":"2006","unstructured":"Burnett AL, Musicki B, Jin L, Bivalacqua TJ . Nitric oxide\/redox-based signalling as a therapeutic target for penile disorders. Expert Opin Ther Targets 2006; 10: 445\u2013457.","journal-title":"Expert Opin Ther Targets"},{"key":"BFijir201611_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMra041001","volume":"351","author":"H Yki-Jarvinen","year":"2004","unstructured":"Yki-Jarvinen H . Thiazolidinediones. N Engl J Med 2004; 351: 1106\u20131118.","journal-title":"N Engl J Med"},{"key":"BFijir201611_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1464-410X.2007.07070.x","volume":"100","author":"I Kovanecz","year":"2007","unstructured":"Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF . Ageing-related corpora veno-occlusive dysfunction in the rat is ameliorated by pioglitazone. BJU Int 2007; 100: 867\u2013874.","journal-title":"BJU Int"},{"key":"BFijir201611_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2265.2003.01767.x","volume":"59","author":"M Gurnell","year":"2003","unstructured":"Gurnell M . PPARgamma and metabolism: insights from the study of human genetic variants. Clin Endocrinol 2003; 59: 267\u2013277.","journal-title":"Clin Endocrinol"},{"key":"BFijir201611_CR20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.urology.2014.07.033","volume":"84","author":"LA Aliperti","year":"2014","unstructured":"Aliperti LA, Lasker GF, Hagan SS, Hellstrom JA, Gokce A, Trost LW et al. Efficacy of pioglitazone on erectile function recovery in a rat model of cavernous nerve injury. Urology 2014; 84: 1122\u20131127.","journal-title":"Urology"},{"key":"BFijir201611_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.mehy.2014.01.022","volume":"82","author":"LA Aliperti","year":"2014","unstructured":"Aliperti LA, Hellstrom WJ . Pioglitazone prevents cavernosal nerve injury after radical prostatectomy. Med Hypotheses 2014; 82: 504.","journal-title":"Med Hypotheses"},{"key":"BFijir201611_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1464-410X.2006.06268.x","volume":"98","author":"I Kovanecz","year":"2006","unstructured":"Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF . Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int 2006; 98: 116\u2013124.","journal-title":"BJU Int"},{"key":"BFijir201611_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/01.HYP.0000116303.71408.c2","volume":"43","author":"MJ Ryan","year":"2004","unstructured":"Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD . PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 2004; 43: 661\u2013666.","journal-title":"Hypertension"},{"key":"BFijir201611_CR24","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/01.CIR.0000097003.49585.5E","volume":"108","author":"L Tao","year":"2003","unstructured":"Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA et al. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Circulation 2003; 108: 2805\u20132811.","journal-title":"Circulation"},{"key":"BFijir201611_CR25","doi-asserted-by":"publisher","first-page":"291656","DOI":"10.1155\/2011\/291656","volume":"2011","author":"Z Zhao","year":"2011","unstructured":"Zhao Z, Luo Z, Wang P, Sun J, Yu H, Cao T et al. Rosiglitazone restores endothelial dysfunction in a rat model of metabolic syndrome through PPARgamma- and PPARdelta-dependent phosphorylation of Akt and eNOS. PPAR Res 2011; 2011: 291656.","journal-title":"PPAR Res"},{"key":"BFijir201611_CR26","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/jcmm.12510","volume":"19","author":"XH Yang","year":"2015","unstructured":"Yang XH, Li P, Yin YL, Tu JH, Dai W, Liu LY et al. Rosiglitazone via PPARgamma-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone. J Cell Mol Med 2015; 19: 826\u2013835.","journal-title":"J Cell Mol Med"},{"key":"BFijir201611_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cardiores.2004.12.025","volume":"66","author":"JB Majithiya","year":"2005","unstructured":"Majithiya JB, Paramar AN, Balaraman R . Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Cardiovasc Res 2005; 66: 150\u2013161.","journal-title":"Cardiovasc Res"},{"key":"BFijir201611_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2007.08.002","volume":"575","author":"S Llorens","year":"2007","unstructured":"Llorens S, Mendizabal Y, Nava E . Effects of pioglitazone and rosiglitazone on aortic vascular function in rat genetic hypertension. Eur J Pharmacol 2007; 575: 105\u2013112.","journal-title":"Eur J Pharmacol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijir201611.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201611","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201611.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:46:33Z","timestamp":1648658793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijir201611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFijir201611"],"URL":"https:\/\/doi.org\/10.1038\/ijir.2016.11","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]},"assertion":[{"value":"12 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}